Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Randomised, Saline-Controlled Investigation of Intra-Articular Growth Hormone and Platelet-Rich Plasma on Joint Health in Adults With Knee and Ankle Arthritis Resistant to Treatment.

NCT06907121 is registered in ClinicalTrials.gov with Integrant Pty Ltd as lead sponsor.

NCT NCT06907121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06907121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Randomised, Saline-Controlled Investigation of Intra-Articular Growth Hormone and Platelet-Rich Plasma on Joint Health in Adults With Knee and Ankle Arthritis Resistant to Treatment.
Lead sponsor
Integrant Pty Ltd
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
December 31, 2027
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis ankle, arthritis knee